Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

63.30p
   
  • Change Today:
      1.10p
  • 52 Week High: 121.60
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.00m
  • Volume: 1,563,632
  • Market Cap: 341.82m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart (02-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 2.7% 0.0%
Div Cover 3.8 2.6
Op Mrgn 13.2% 19.2%
ROCE 46.4%  
Latest F'cast
P/E 9.9 14.0
PEG 0.4 n/a
Pr/Revenue 2.1 2.0
Pr/Book 1.2  
Latest F'cast
Revenue 25.7% 4.9%
PBT 39.5% 80.8%
EPS 25.0% -30.6%
DPS 5.0% 2.8%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 171.22 32.83 4.44p 14.3 n/a -31% 1.74p 0.0%
31-Dec-23 189.57 43.33 5.47p 11.6 0.5 +23% 1.83p 0.0%
31-Dec-24 211.70 50.69 6.66p 9.5 0.4 +22% 1.97p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Appointment of NED and SID 01-Feb-2023 07:00 RNS
Notification of Major Holdings 30-Jan-2023 17:18 RNS
Full Year Trading Update 17-Jan-2023 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 63.30p
Change Today 1.10p
% Change 1.77 %
52 Week High 121.60
52 Week Low 35.30
Volume 1,563,632
Shares Issued 540.00m
Market Cap 341.82m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.38% below the market average8.38% below the market average8.38% below the market average8.38% below the market average8.38% below the market average
62.07% above the sector average62.07% above the sector average62.07% above the sector average62.07% above the sector average62.07% above the sector average
Price Trend
73.16% below the market average73.16% below the market average73.16% below the market average73.16% below the market average73.16% below the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average
Income
36.41% above the market average36.41% above the market average36.41% above the market average36.41% above the market average36.41% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
13.36% below the market average13.36% below the market average13.36% below the market average13.36% below the market average13.36% below the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 22-Dec-22 09-Jun-22
Paid 19-Jan-23 07-Jul-22
Amount 0.59p 1.13p

Trades for 02-Feb-2023

Time Volume / Share Price
16:35 1,711 @ 63.30p
16:35 2,361 @ 63.30p
16:35 75,000 @ 63.20p
16:35 105,464 @ 63.30p
16:35 1 @ 63.30p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page